[Effect of YC-1 on HIF-1 alpha and VEGF expression in human hepatocarcinoma cell lines].
Wang
Shun-xiang
SX
Department of Hepatobiliary Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China. gdwangsx@163.com
Pei
Zhi-zhong
ZZ
Wu
Xiao-hui
XH
Li
Jian-kun
JK
Yang
Yong-jiang
YJ
D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism*; D007191:Indazoles / Q000494:pharmacology*; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D042442:Vascular Endothelial Growth Factors / Q000235:genetics / Q000378:metabolism*
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D007191:Indazoles; D012333:RNA, Messenger; D042442:Vascular Endothelial Growth Factors; C090937:3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole